BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 51258190 COC(=O)CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C25H30N2O4/c1-30-23(28)18-22-24(29)27(21-10-6-3-7-11-21)19-25(31-22)13-16-26(17-14-25)15-12-20-8-4-2-5-9-20/h2-11,22H,12-19H2,1H3 NWICMXBOJMLOIB-UHFFFAOYSA-N 50514226 CHEMBL4446209 Mu-type opioid receptor Homo sapiens 92 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514226&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562469 440722808 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258191 COc1cccc(c1)N1CC2(CCN(CCc3ccccc3)CC2)OC(C)C1=O InChI=1S/C24H30N2O3/c1-19-23(27)26(21-9-6-10-22(17-21)28-2)18-24(29-19)12-15-25(16-13-24)14-11-20-7-4-3-5-8-20/h3-10,17,19H,11-16,18H2,1-2H3 ZEIMIZKOLIBIEH-UHFFFAOYSA-N 50514227 CHEMBL4550656 Mu-type opioid receptor Homo sapiens 126 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514227 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514227&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562556 440722809 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258192 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ncccc1C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(20-19(23(24,25)26)8-5-12-27-20)16-22(31-17)10-14-28(15-11-22)13-9-18-6-3-2-4-7-18/h2-8,12,17H,9-11,13-16H2,1H3 QVSZFVNYJYNUGG-UHFFFAOYSA-N 50514228 CHEMBL4448670 Mu-type opioid receptor Homo sapiens 262 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514228 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514228&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562402 440722810 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258193 O=C1COC2(CCN(CCc3ccccc3)C2)CN1c1ccccc1 InChI=1S/C21H24N2O2/c24-20-15-25-21(17-23(20)19-9-5-2-6-10-19)12-14-22(16-21)13-11-18-7-3-1-4-8-18/h1-10H,11-17H2 XFVLQPBMVRXGBD-UHFFFAOYSA-N 50514229 CHEMBL4540995 Mu-type opioid receptor Homo sapiens >1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514229 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514229&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562428 440722811 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258194 CC1OC2(CCN(CCc3ccccc3NC(C)=O)CC2)CN(C1=O)c1ccccc1 InChI=1S/C25H31N3O3/c1-19-24(30)28(22-9-4-3-5-10-22)18-25(31-19)13-16-27(17-14-25)15-12-21-8-6-7-11-23(21)26-20(2)29/h3-11,19H,12-18H2,1-2H3,(H,26,29) BROIIODYMJKYAW-UHFFFAOYSA-N 50514230 CHEMBL4451838 Mu-type opioid receptor Homo sapiens 190 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514230 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514230&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 126744949 440722812 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258195 C[C@H]1OC2(CCN(CCc3cccc(NC(C)=O)c3)CC2)CN(C1=O)c1ccccc1 |r| InChI=1S/C25H31N3O3/c1-19-24(30)28(23-9-4-3-5-10-23)18-25(31-19)12-15-27(16-13-25)14-11-21-7-6-8-22(17-21)26-20(2)29/h3-10,17,19H,11-16,18H2,1-2H3,(H,26,29) GFMRIFXLIUPAFX-UHFFFAOYSA-N 50514231 CHEMBL4525653 Mu-type opioid receptor Homo sapiens 46 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514231 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514231&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 126744799 440722813 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258196 CC1OC2(CCN(CCc3ccccc3F)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H27FN2O2/c1-18-22(27)26(20-8-3-2-4-9-20)17-23(28-18)12-15-25(16-13-23)14-11-19-7-5-6-10-21(19)24/h2-10,18H,11-17H2,1H3 ZAIUBAOMYCTCCK-UHFFFAOYSA-N 50514232 CHEMBL4536259 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 800 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514232&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118562384 440722814 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258197 CC1OC2(CCN(CCc3ccc(F)cc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H27FN2O2/c1-18-22(27)26(21-5-3-2-4-6-21)17-23(28-18)12-15-25(16-13-23)14-11-19-7-9-20(24)10-8-19/h2-10,18H,11-17H2,1H3 APZHXGIRWMPKDR-UHFFFAOYSA-N 50514233 CHEMBL4544352 Mu-type opioid receptor Homo sapiens 25 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514233 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514233&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562567 440722815 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258198 C[C@H]1OC2(CCN(CCc3cccc(NC(C)=O)c3)CC2)CN(C1=O)c1ccccc1 |r| InChI=1S/C25H31N3O3/c1-19-24(30)28(23-9-4-3-5-10-23)18-25(31-19)12-15-27(16-13-25)14-11-21-7-6-8-22(17-21)26-20(2)29/h3-10,17,19H,11-16,18H2,1-2H3,(H,26,29) GFMRIFXLIUPAFX-UHFFFAOYSA-N 50514231 CHEMBL4525653 Mu-type opioid receptor Homo sapiens 69 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514231 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514231&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 126744799 440722813 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258199 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H28N2O2/c1-19-22(26)25(21-10-6-3-7-11-21)18-23(27-19)13-16-24(17-14-23)15-12-20-8-4-2-5-9-20/h2-11,19H,12-18H2,1H3 RSVBTLSIVBWMNF-UHFFFAOYSA-N 50514234 CHEMBL4541206 Sigma non-opioid intracellular receptor 1 Homo sapiens 6.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514234 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514234&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 102004349 440722816 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258200 CC1OC2(CCN(CCc3ccc(NC(C)=O)cc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C25H31N3O3/c1-19-24(30)28(23-6-4-3-5-7-23)18-25(31-19)13-16-27(17-14-25)15-12-21-8-10-22(11-9-21)26-20(2)29/h3-11,19H,12-18H2,1-2H3,(H,26,29) HVTXQDWADTYROW-UHFFFAOYSA-N 50514235 CHEMBL4463901 Sigma non-opioid intracellular receptor 1 Homo sapiens 237 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514235 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514235&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567593 440722817 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258201 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H28N2O2/c1-19-22(26)25(21-10-6-3-7-11-21)18-23(27-19)13-16-24(17-14-23)15-12-20-8-4-2-5-9-20/h2-11,19H,12-18H2,1H3 RSVBTLSIVBWMNF-UHFFFAOYSA-N 50514234 CHEMBL4541206 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 400 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514234 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514234&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 102004349 440722816 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258202 COc1cccc(c1)N1CC2(CCN(CCc3ccccc3)CC2)OC(C)C1=O InChI=1S/C24H30N2O3/c1-19-23(27)26(21-9-6-10-22(17-21)28-2)18-24(29-19)12-15-25(16-13-24)14-11-20-7-4-3-5-8-20/h3-10,17,19H,11-16,18H2,1-2H3 ZEIMIZKOLIBIEH-UHFFFAOYSA-N 50514227 CHEMBL4550656 Mu-type opioid receptor Homo sapiens 304 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514227 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514227&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562556 440722809 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258203 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ncccc1F InChI=1S/C22H26FN3O2/c1-17-21(27)26(20-19(23)8-5-12-24-20)16-22(28-17)10-14-25(15-11-22)13-9-18-6-3-2-4-7-18/h2-8,12,17H,9-11,13-16H2,1H3 JHDWAFRPXSZUKN-UHFFFAOYSA-N 50514236 CHEMBL4483643 Mu-type opioid receptor Homo sapiens 199 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514236 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514236&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567747 440722818 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258204 OC(=O)CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H28N2O4/c27-22(28)17-21-23(29)26(20-9-5-2-6-10-20)18-24(30-21)12-15-25(16-13-24)14-11-19-7-3-1-4-8-19/h1-10,21H,11-18H2,(H,27,28) BHHDOKVEJNGVDJ-UHFFFAOYSA-N 50514237 CHEMBL4546076 Sigma non-opioid intracellular receptor 1 Homo sapiens >1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514237 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514237&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567678 440722819 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258205 COc1ccc(cc1)N1CC2(CCN(CCc3ccccc3)CC2)OC(C)C1=O InChI=1S/C24H30N2O3/c1-19-23(27)26(21-8-10-22(28-2)11-9-21)18-24(29-19)13-16-25(17-14-24)15-12-20-6-4-3-5-7-20/h3-11,19H,12-18H2,1-2H3 RCWOVKNRESAXSE-UHFFFAOYSA-N 50514238 CHEMBL4457602 Sigma non-opioid intracellular receptor 1 Homo sapiens 14 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514238 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514238&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562522 440722820 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258206 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cncc(F)c1 InChI=1S/C22H26FN3O2/c1-17-21(27)26(20-13-19(23)14-24-15-20)16-22(28-17)8-11-25(12-9-22)10-7-18-5-3-2-4-6-18/h2-6,13-15,17H,7-12,16H2,1H3 HJJBGZORBJLFRB-UHFFFAOYSA-N 50514239 CHEMBL4470425 Sigma non-opioid intracellular receptor 1 Homo sapiens 3.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514239 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514239&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567547 440722821 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258207 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H28N2O2/c1-19-22(26)25(21-10-6-3-7-11-21)18-23(27-19)13-16-24(17-14-23)15-12-20-8-4-2-5-9-20/h2-11,19H,12-18H2,1H3 RSVBTLSIVBWMNF-UHFFFAOYSA-N 50514234 CHEMBL4541206 Mu-type opioid receptor Homo sapiens 14 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514234 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514234&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 102004349 440722816 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258208 OC(=O)CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H28N2O4/c27-22(28)17-21-23(29)26(20-9-5-2-6-10-20)18-24(30-21)12-15-25(16-13-24)14-11-19-7-3-1-4-8-19/h1-10,21H,11-18H2,(H,27,28) BHHDOKVEJNGVDJ-UHFFFAOYSA-N 50514237 CHEMBL4546076 Mu-type opioid receptor Homo sapiens >1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514237 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514237&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567678 440722819 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258209 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ncccc1F InChI=1S/C22H26FN3O2/c1-17-21(27)26(20-19(23)8-5-12-24-20)16-22(28-17)10-14-25(15-11-22)13-9-18-6-3-2-4-7-18/h2-8,12,17H,9-11,13-16H2,1H3 JHDWAFRPXSZUKN-UHFFFAOYSA-N 50514236 CHEMBL4483643 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1200 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514236 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514236&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118567747 440722818 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258210 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ncccc1C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(20-19(23(24,25)26)8-5-12-27-20)16-22(31-17)10-14-28(15-11-22)13-9-18-6-3-2-4-7-18/h2-8,12,17H,9-11,13-16H2,1H3 QVSZFVNYJYNUGG-UHFFFAOYSA-N 50514228 CHEMBL4448670 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 8200 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514228 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514228&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118562402 440722810 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258211 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cncc(F)c1 InChI=1S/C22H26FN3O2/c1-17-21(27)26(20-13-19(23)14-24-15-20)16-22(28-17)8-11-25(12-9-22)10-7-18-5-3-2-4-6-18/h2-6,13-15,17H,7-12,16H2,1H3 HJJBGZORBJLFRB-UHFFFAOYSA-N 50514239 CHEMBL4470425 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1100 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514239 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514239&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118567547 440722821 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258212 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cccnc1C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(19-8-5-12-27-20(19)23(24,25)26)16-22(31-17)10-14-28(15-11-22)13-9-18-6-3-2-4-7-18/h2-8,12,17H,9-11,13-16H2,1H3 JHFOVHVTTIYFHX-UHFFFAOYSA-N 50514240 CHEMBL4535897 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 3800 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514240&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118567545 440722822 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258213 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cncc(c1)C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(20-13-19(14-27-15-20)23(24,25)26)16-22(31-17)8-11-28(12-9-22)10-7-18-5-3-2-4-6-18/h2-6,13-15,17H,7-12,16H2,1H3 BMUHJRCSESNQGV-UHFFFAOYSA-N 50514241 CHEMBL4593220 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 500 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514241 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514241&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118567534 440722823 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258214 CC1OC2(CCN(CCc3ccc(F)cc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H27FN2O2/c1-18-22(27)26(21-5-3-2-4-6-21)17-23(28-18)12-15-25(16-13-23)14-11-19-7-9-20(24)10-8-19/h2-10,18H,11-17H2,1H3 APZHXGIRWMPKDR-UHFFFAOYSA-N 50514233 CHEMBL4544352 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 100 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514233 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514233&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118562567 440722815 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258215 CC1OC2(CCN(CCc3cccc(NC(C)=O)c3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C25H31N3O3/c1-19-24(30)28(23-9-4-3-5-10-23)18-25(31-19)12-15-27(16-13-25)14-11-21-7-6-8-22(17-21)26-20(2)29/h3-10,17,19H,11-16,18H2,1-2H3,(H,26,29) GFMRIFXLIUPAFX-UHFFFAOYSA-N 50514242 CHEMBL4573960 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514242 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514242&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 126744800 440722824 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258216 CC1OC2(CCN(CCc3cccc(c3)C#N)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H27N3O2/c1-19-23(28)27(22-8-3-2-4-9-22)18-24(29-19)11-14-26(15-12-24)13-10-20-6-5-7-21(16-20)17-25/h2-9,16,19H,10-15,18H2,1H3 ORXZYLUNARJXOL-UHFFFAOYSA-N 50514243 CHEMBL4463621 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 600 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514243&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118562359 440722825 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258217 C[C@H]1OC2(CCN(CCc3ccccc3F)CC2)CN(C1=O)c1ncccc1C(F)(F)F |r| InChI=1S/C23H25F4N3O2/c1-16-21(31)30(20-18(23(25,26)27)6-4-11-28-20)15-22(32-16)9-13-29(14-10-22)12-8-17-5-2-3-7-19(17)24/h2-7,11,16H,8-10,12-15H2,1H3 FDTFECQDLRIBOA-UHFFFAOYSA-N 50514244 CHEMBL4522004 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 6600 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514244 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514244&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118567531 440722826 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258218 C[C@H]1OC2(CCN(CCc3cccc(NC(C)=O)c3)CC2)CN(C1=O)c1ccccc1 |r| InChI=1S/C25H31N3O3/c1-19-24(30)28(23-9-4-3-5-10-23)18-25(31-19)12-15-27(16-13-25)14-11-21-7-6-8-22(17-21)26-20(2)29/h3-10,17,19H,11-16,18H2,1-2H3,(H,26,29) GFMRIFXLIUPAFX-UHFFFAOYSA-N 50514231 CHEMBL4525653 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514231 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514231&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 126744799 440722813 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258219 Fc1ccccc1CCN1CCC2(CC1)CN(C(=O)C1(CC1)O2)c1cccnc1C(F)(F)F InChI=1S/C24H25F4N3O2/c25-18-5-2-1-4-17(18)7-13-30-14-10-22(11-15-30)16-31(21(32)23(33-22)8-9-23)19-6-3-12-29-20(19)24(26,27)28/h1-6,12H,7-11,13-16H2 QNSPFRSAEHVDGL-UHFFFAOYSA-N 50514245 CHEMBL4461774 Alpha-1A adrenergic receptor Homo sapiens 470 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514245 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5868&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514245&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567543 440722827 1 MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV 9M4T,9M4Q,7YMH,7YM8 Alpha-1A adrenergic receptor ADA1A_HUMAN P35348 A8K0I3 B0ZBD1 B0ZBD2 B0ZBD4 B0ZBD5 B0ZBD6 B0ZBD8 B0ZBD9 O60451 Q13675 Q13729 Q4VBM7 Q6RUJ4 Q6RUJ5 Q6RUJ7 Q6RUJ8 Q6RUJ9 Q96RE8 Q9UD63 Q9UD67 51258220 CN1CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)OC InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3 BRUQQQPBMZOVGD-UHFFFAOYSA-N 50370595 US9233167, Oxycodone::Oxycontin::OXYCODONE::US1184575, oxycodone Mu-type opioid receptor Homo sapiens 12 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50370595 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50370595&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search OOX 7U63 5284603 160849697 DB00497 C08026 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258221 Cc1cc(OCCN2CCOCC2)nn1-c1ccc2ccccc2c1 InChI=1S/C20H23N3O2/c1-16-14-20(25-13-10-22-8-11-24-12-9-22)21-23(16)19-7-6-17-4-2-3-5-18(17)15-19/h2-7,14-15H,8-13H2,1H3 DGPGXHRHNRYVDH-UHFFFAOYSA-N 50396352 CHEMBL2170062 Mu-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50396352 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50396352&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 44247568 163345376 CHEMBL2170062 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258222 O=C1OC2(CN1c1ccccc1)CCN(CCc1ccccc1)CC2 InChI=1S/C21H24N2O2/c24-20-23(19-9-5-2-6-10-19)17-21(25-20)12-15-22(16-13-21)14-11-18-7-3-1-4-8-18/h1-10H,11-17H2 QMZYZVGBMAHPDU-UHFFFAOYSA-N 50514246 CHEMBL4461864 Mu-type opioid receptor Homo sapiens 401 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514246 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514246&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 155528829 440722828 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258223 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H28N2O2/c1-19-22(26)25(21-10-6-3-7-11-21)18-23(27-19)13-16-24(17-14-23)15-12-20-8-4-2-5-9-20/h2-11,19H,12-18H2,1H3 RSVBTLSIVBWMNF-UHFFFAOYSA-N 50514234 CHEMBL4541206 Mu-type opioid receptor Homo sapiens 7.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514234 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514234&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 102004349 440722816 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258224 C[C@H]1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 |r| InChI=1S/C23H28N2O2/c1-19-22(26)25(21-10-6-3-7-11-21)18-23(27-19)13-16-24(17-14-23)15-12-20-8-4-2-5-9-20/h2-11,19H,12-18H2,1H3 RSVBTLSIVBWMNF-UHFFFAOYSA-N 50514247 CHEMBL4450665 Mu-type opioid receptor Homo sapiens 8.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514247&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562584 440722829 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258225 CCC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H30N2O2/c1-2-22-23(27)26(21-11-7-4-8-12-21)19-24(28-22)14-17-25(18-15-24)16-13-20-9-5-3-6-10-20/h3-12,22H,2,13-19H2,1H3 ZPNOUFCAZBAVMA-UHFFFAOYSA-N 50514248 CHEMBL4515812 Mu-type opioid receptor Homo sapiens 3.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514248&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562510 440722830 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258226 CC(C)C1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C25H32N2O2/c1-20(2)23-24(28)27(22-11-7-4-8-12-22)19-25(29-23)14-17-26(18-15-25)16-13-21-9-5-3-6-10-21/h3-12,20,23H,13-19H2,1-2H3 TZGRGSUVKBRDCV-UHFFFAOYSA-N 50514249 CHEMBL4436170 Mu-type opioid receptor Homo sapiens 1.000000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514249&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562375 440722831 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258227 OC(=O)CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H28N2O4/c27-22(28)17-21-23(29)26(20-9-5-2-6-10-20)18-24(30-21)12-15-25(16-13-24)14-11-19-7-3-1-4-8-19/h1-10,21H,11-18H2,(H,27,28) BHHDOKVEJNGVDJ-UHFFFAOYSA-N 50514237 CHEMBL4546076 Mu-type opioid receptor Homo sapiens >1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514237 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514237&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567678 440722819 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258228 CN(C)C(=O)CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C26H33N3O3/c1-27(2)24(30)19-23-25(31)29(22-11-7-4-8-12-22)20-26(32-23)14-17-28(18-15-26)16-13-21-9-5-3-6-10-21/h3-12,23H,13-20H2,1-2H3 SGLYTKUAFQGFJG-UHFFFAOYSA-N 50514250 CHEMBL4458456 Mu-type opioid receptor Homo sapiens 636 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514250&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567549 440722832 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258229 O=C1N(CC2(CCN(CCc3ccccc3)CC2)OC11CC1)c1ccccc1 InChI=1S/C24H28N2O2/c27-22-24(12-13-24)28-23(19-26(22)21-9-5-2-6-10-21)14-17-25(18-15-23)16-11-20-7-3-1-4-8-20/h1-10H,11-19H2 ZCMSPFVAMUOJIK-UHFFFAOYSA-N 50514251 CHEMBL4438550 Mu-type opioid receptor Homo sapiens 15 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514251&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562538 440722833 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258230 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1Cl InChI=1S/C23H27ClN2O2/c1-18-22(27)26(21-10-6-5-9-20(21)24)17-23(28-18)12-15-25(16-13-23)14-11-19-7-3-2-4-8-19/h2-10,18H,11-17H2,1H3 BLXCYXQUSIEXTF-UHFFFAOYSA-N 50514252 CHEMBL4452042 Mu-type opioid receptor Homo sapiens 3.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514252&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567608 440722834 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258231 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1F InChI=1S/C23H27FN2O2/c1-18-22(27)26(21-10-6-5-9-20(21)24)17-23(28-18)12-15-25(16-13-23)14-11-19-7-3-2-4-8-19/h2-10,18H,11-17H2,1H3 LBUMRHRNIHWDBD-UHFFFAOYSA-N 50514253 CHEMBL4584335 Mu-type opioid receptor Homo sapiens 8.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514253&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567604 440722835 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258232 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cccc(O)c1 InChI=1S/C23H28N2O3/c1-18-22(27)25(20-8-5-9-21(26)16-20)17-23(28-18)11-14-24(15-12-23)13-10-19-6-3-2-4-7-19/h2-9,16,18,26H,10-15,17H2,1H3 SVTYKQJVCXBJNT-UHFFFAOYSA-N 50514254 CHEMBL4471711 Mu-type opioid receptor Homo sapiens 727 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514254&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567552 440722836 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258233 COc1ccc(cc1)N1CC2(CCN(CCc3ccccc3)CC2)OC(C)C1=O InChI=1S/C24H30N2O3/c1-19-23(27)26(21-8-10-22(28-2)11-9-21)18-24(29-19)13-16-25(17-14-24)15-12-20-6-4-3-5-7-20/h3-11,19H,12-18H2,1-2H3 RCWOVKNRESAXSE-UHFFFAOYSA-N 50514238 CHEMBL4457602 Mu-type opioid receptor Homo sapiens >1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514238 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514238&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562522 440722820 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258234 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cccnc1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-8-5-12-23-16-20)17-22(27-18)10-14-24(15-11-22)13-9-19-6-3-2-4-7-19/h2-8,12,16,18H,9-11,13-15,17H2,1H3 XMHDSSGOIGKARI-UHFFFAOYSA-N 50514255 CHEMBL4440055 Mu-type opioid receptor Homo sapiens 304 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514255 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514255&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562502 440722837 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258235 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cnccn1 InChI=1S/C21H26N4O2/c1-17-20(26)25(19-15-22-10-11-23-19)16-21(27-17)8-13-24(14-9-21)12-7-18-5-3-2-4-6-18/h2-6,10-11,15,17H,7-9,12-14,16H2,1H3 PFSGEFYLEHABKV-UHFFFAOYSA-N 50514256 CHEMBL4439718 Mu-type opioid receptor Homo sapiens 304 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514256&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567605 440722838 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258236 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cccc(n1)C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(20-9-5-8-19(27-20)23(24,25)26)16-22(31-17)11-14-28(15-12-22)13-10-18-6-3-2-4-7-18/h2-9,17H,10-16H2,1H3 MNWMAFFICUVGRW-UHFFFAOYSA-N 50514257 CHEMBL4538620 Mu-type opioid receptor Homo sapiens 90 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514257 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514257&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567743 440722839 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258237 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cncc(F)c1 InChI=1S/C22H26FN3O2/c1-17-21(27)26(20-13-19(23)14-24-15-20)16-22(28-17)8-11-25(12-9-22)10-7-18-5-3-2-4-6-18/h2-6,13-15,17H,7-12,16H2,1H3 HJJBGZORBJLFRB-UHFFFAOYSA-N 50514239 CHEMBL4470425 Mu-type opioid receptor Homo sapiens 204 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514239 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514239&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567547 440722821 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258238 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccc(nc1)C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(19-7-8-20(27-15-19)23(24,25)26)16-22(31-17)10-13-28(14-11-22)12-9-18-5-3-2-4-6-18/h2-8,15,17H,9-14,16H2,1H3 SBBYFXIXMFNMNQ-UHFFFAOYSA-N 50514258 CHEMBL4560624 Mu-type opioid receptor Homo sapiens >1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514258&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567742 440722840 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258239 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cncc(c1)C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(20-13-19(14-27-15-20)23(24,25)26)16-22(31-17)8-11-28(12-9-22)10-7-18-5-3-2-4-6-18/h2-6,13-15,17H,7-12,16H2,1H3 BMUHJRCSESNQGV-UHFFFAOYSA-N 50514241 CHEMBL4593220 Mu-type opioid receptor Homo sapiens 261 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514241 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514241&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567534 440722823 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258240 CC1OC2(CCN(CCc3cccc(F)c3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H27FN2O2/c1-18-22(27)26(21-8-3-2-4-9-21)17-23(28-18)11-14-25(15-12-23)13-10-19-6-5-7-20(24)16-19/h2-9,16,18H,10-15,17H2,1H3 BDLPANZXJUPVDU-UHFFFAOYSA-N 50514259 CHEMBL4534193 Mu-type opioid receptor Homo sapiens 10.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514259 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514259&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562440 440722841 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258241 CC1OC2(CCN(CCc3ccc(F)cc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H27FN2O2/c1-18-22(27)26(21-5-3-2-4-6-21)17-23(28-18)12-15-25(16-13-23)14-11-19-7-9-20(24)10-8-19/h2-10,18H,11-17H2,1H3 APZHXGIRWMPKDR-UHFFFAOYSA-N 50514233 CHEMBL4544352 Mu-type opioid receptor Homo sapiens 19 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514233 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514233&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562567 440722815 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258242 CC1OC2(CCN(CCc3ccc(NC(C)=O)cc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C25H31N3O3/c1-19-24(30)28(23-6-4-3-5-7-23)18-25(31-19)13-16-27(17-14-25)15-12-21-8-10-22(11-9-21)26-20(2)29/h3-11,19H,12-18H2,1-2H3,(H,26,29) HVTXQDWADTYROW-UHFFFAOYSA-N 50514235 CHEMBL4463901 Mu-type opioid receptor Homo sapiens >1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514235 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514235&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567593 440722817 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258243 CC1OC2(CCN(CCc3cccc(c3)C#N)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H27N3O2/c1-19-23(28)27(22-8-3-2-4-9-22)18-24(29-19)11-14-26(15-12-24)13-10-20-6-5-7-21(16-20)17-25/h2-9,16,19H,10-15,18H2,1H3 ORXZYLUNARJXOL-UHFFFAOYSA-N 50514243 CHEMBL4463621 Mu-type opioid receptor Homo sapiens 49 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514243&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562359 440722825 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258244 CC1OC2(CCN(CCc3ccncc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-5-3-2-4-6-20)17-22(27-18)10-15-24(16-11-22)14-9-19-7-12-23-13-8-19/h2-8,12-13,18H,9-11,14-17H2,1H3 PIOCDECZIQSCFV-UHFFFAOYSA-N 50514260 CHEMBL4445578 Mu-type opioid receptor Homo sapiens 516 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514260 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514260&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567672 440722842 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258245 CC1OC2(CCN(CCc3ccccn3)CC2)CN(C1=O)c1cnccc1C(F)(F)F InChI=1S/C22H25F3N4O2/c1-16-20(30)29(19-14-26-10-5-18(19)22(23,24)25)15-21(31-16)7-12-28(13-8-21)11-6-17-4-2-3-9-27-17/h2-5,9-10,14,16H,6-8,11-13,15H2,1H3 DBYOLMQXHPITEO-UHFFFAOYSA-N 50514261 CHEMBL4540888 Mu-type opioid receptor Homo sapiens 127 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514261 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514261&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567689 440722843 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258246 C[C@H]1OC2(CCN(CCc3ccccc3F)CC2)CN(C1=O)c1cnccc1C(F)(F)F |r| InChI=1S/C23H25F4N3O2/c1-16-21(31)30(20-14-28-10-6-18(20)23(25,26)27)15-22(32-16)8-12-29(13-9-22)11-7-17-4-2-3-5-19(17)24/h2-6,10,14,16H,7-9,11-13,15H2,1H3 INCPDVXLHDEOLM-UHFFFAOYSA-N 50514262 CHEMBL4576031 Mu-type opioid receptor Homo sapiens 11 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514262 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514262&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 126744972 440722844 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258247 CN1CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)OC InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3 BRUQQQPBMZOVGD-UHFFFAOYSA-N 50370595 US9233167, Oxycodone::Oxycontin::OXYCODONE::US1184575, oxycodone Mu-type opioid receptor Homo sapiens 17 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50370595 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50370595&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search OOX 7U63 5284603 160849697 DB00497 C08026 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258248 Cc1cc(OCCN2CCOCC2)nn1-c1ccc2ccccc2c1 InChI=1S/C20H23N3O2/c1-16-14-20(25-13-10-22-8-11-24-12-9-22)21-23(16)19-7-6-17-4-2-3-5-18(17)15-19/h2-7,14-15H,8-13H2,1H3 DGPGXHRHNRYVDH-UHFFFAOYSA-N 50396352 CHEMBL2170062 Mu-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50396352 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50396352&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 44247568 163345376 CHEMBL2170062 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258249 O=C1COC2(CCN(Cc3ccccc3)CC2)CN1c1ccccc1 InChI=1S/C21H24N2O2/c24-20-16-25-21(17-23(20)19-9-5-2-6-10-19)11-13-22(14-12-21)15-18-7-3-1-4-8-18/h1-10H,11-17H2 KBEJBFGBZGNZHJ-UHFFFAOYSA-N 50514263 CHEMBL4446292 Mu-type opioid receptor Homo sapiens 3044 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514263 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514263&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567654 440722845 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258250 O=C1OC2(CN1c1ccccc1)CCN(CCc1ccccc1)CC2 InChI=1S/C21H24N2O2/c24-20-23(19-9-5-2-6-10-19)17-21(25-20)12-15-22(16-13-21)14-11-18-7-3-1-4-8-18/h1-10H,11-17H2 QMZYZVGBMAHPDU-UHFFFAOYSA-N 50514246 CHEMBL4461864 Mu-type opioid receptor Homo sapiens >1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514246 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514246&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 155528829 440722828 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258251 O=C1COC2(CCN(CCc3ccccc3)C2)CN1c1ccccc1 InChI=1S/C21H24N2O2/c24-20-15-25-21(17-23(20)19-9-5-2-6-10-19)12-14-22(16-21)13-11-18-7-3-1-4-8-18/h1-10H,11-17H2 XFVLQPBMVRXGBD-UHFFFAOYSA-N 50514229 CHEMBL4540995 Mu-type opioid receptor Homo sapiens >1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514229 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514229&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562428 440722811 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258252 C[C@@H]1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 |r| InChI=1S/C23H28N2O2/c1-19-22(26)25(21-10-6-3-7-11-21)18-23(27-19)13-16-24(17-14-23)15-12-20-8-4-2-5-9-20/h2-11,19H,12-18H2,1H3 RSVBTLSIVBWMNF-UHFFFAOYSA-N 50514264 CHEMBL4467749 Mu-type opioid receptor Homo sapiens 264 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514264 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514264&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562451 440722846 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258253 CC(C)C1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C25H32N2O2/c1-20(2)23-24(28)27(22-11-7-4-8-12-22)19-25(29-23)14-17-26(18-15-25)16-13-21-9-5-3-6-10-21/h3-12,20,23H,13-19H2,1-2H3 TZGRGSUVKBRDCV-UHFFFAOYSA-N 50514249 CHEMBL4436170 Mu-type opioid receptor Homo sapiens 0.200000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514249&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562375 440722831 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258254 COCC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H30N2O3/c1-28-18-22-23(27)26(21-10-6-3-7-11-21)19-24(29-22)13-16-25(17-14-24)15-12-20-8-4-2-5-9-20/h2-11,22H,12-19H2,1H3 CAXQLHIXVZVOAJ-UHFFFAOYSA-N 50514265 CHEMBL4439285 Mu-type opioid receptor Homo sapiens 32 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514265 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514265&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567313 440722847 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258255 OCC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H28N2O3/c26-17-21-22(27)25(20-9-5-2-6-10-20)18-23(28-21)12-15-24(16-13-23)14-11-19-7-3-1-4-8-19/h1-10,21,26H,11-18H2 QGQRUYNHBMRUGE-UHFFFAOYSA-N 50514266 CHEMBL4459117 Mu-type opioid receptor Homo sapiens 125 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514266 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514266&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562362 440722848 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258256 COC(=O)CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C25H30N2O4/c1-30-23(28)18-22-24(29)27(21-10-6-3-7-11-21)19-25(31-22)13-16-26(17-14-25)15-12-20-8-4-2-5-9-20/h2-11,22H,12-19H2,1H3 NWICMXBOJMLOIB-UHFFFAOYSA-N 50514226 CHEMBL4446209 Mu-type opioid receptor Homo sapiens 181 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514226&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562469 440722808 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258257 CN(C)C(=O)CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C26H33N3O3/c1-27(2)24(30)19-23-25(31)29(22-11-7-4-8-12-22)20-26(32-23)14-17-28(18-15-26)16-13-21-9-5-3-6-10-21/h3-12,23H,13-20H2,1-2H3 SGLYTKUAFQGFJG-UHFFFAOYSA-N 50514250 CHEMBL4458456 Mu-type opioid receptor Homo sapiens >1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514250&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567549 440722832 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258258 O=C1N(CC2(CCN(CCc3ccccc3)CC2)OC11CC1)c1ccccc1 InChI=1S/C24H28N2O2/c27-22-24(12-13-24)28-23(19-26(22)21-9-5-2-6-10-21)14-17-25(18-15-23)16-11-20-7-3-1-4-8-20/h1-10H,11-19H2 ZCMSPFVAMUOJIK-UHFFFAOYSA-N 50514251 CHEMBL4438550 Mu-type opioid receptor Homo sapiens 11 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514251&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562538 440722833 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258259 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1Cl InChI=1S/C23H27ClN2O2/c1-18-22(27)26(21-10-6-5-9-20(21)24)17-23(28-18)12-15-25(16-13-23)14-11-19-7-3-2-4-8-19/h2-10,18H,11-17H2,1H3 BLXCYXQUSIEXTF-UHFFFAOYSA-N 50514252 CHEMBL4452042 Mu-type opioid receptor Homo sapiens 1.000000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514252&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567608 440722834 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258260 COc1ccccc1N1CC2(CCN(CCc3ccccc3)CC2)OC(C)C1=O InChI=1S/C24H30N2O3/c1-19-23(27)26(21-10-6-7-11-22(21)28-2)18-24(29-19)13-16-25(17-14-24)15-12-20-8-4-3-5-9-20/h3-11,19H,12-18H2,1-2H3 SKDFRXDSPIOUSP-UHFFFAOYSA-N 50514267 CHEMBL4526087 Mu-type opioid receptor Homo sapiens 144 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514267 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514267&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567744 440722849 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258261 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cccc(O)c1 InChI=1S/C23H28N2O3/c1-18-22(27)25(20-8-5-9-21(26)16-20)17-23(28-18)11-14-24(15-12-23)13-10-19-6-3-2-4-7-19/h2-9,16,18,26H,10-15,17H2,1H3 SVTYKQJVCXBJNT-UHFFFAOYSA-N 50514254 CHEMBL4471711 Mu-type opioid receptor Homo sapiens >1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514254&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567552 440722836 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258262 COc1ccc(cc1)N1CC2(CCN(CCc3ccccc3)CC2)OC(C)C1=O InChI=1S/C24H30N2O3/c1-19-23(27)26(21-8-10-22(28-2)11-9-21)18-24(29-19)13-16-25(17-14-24)15-12-20-6-4-3-5-7-20/h3-11,19H,12-18H2,1-2H3 RCWOVKNRESAXSE-UHFFFAOYSA-N 50514238 CHEMBL4457602 Mu-type opioid receptor Homo sapiens >1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514238 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514238&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562522 440722820 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258263 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccn1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-9-5-6-13-23-20)17-22(27-18)11-15-24(16-12-22)14-10-19-7-3-2-4-8-19/h2-9,13,18H,10-12,14-17H2,1H3 XFDIYQRODQBNBJ-UHFFFAOYSA-N 50514268 CHEMBL4578955 Mu-type opioid receptor Homo sapiens 1987 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514268 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514268&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567606 440722850 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258264 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cccnc1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-8-5-12-23-16-20)17-22(27-18)10-14-24(15-11-22)13-9-19-6-3-2-4-7-19/h2-8,12,16,18H,9-11,13-15,17H2,1H3 XMHDSSGOIGKARI-UHFFFAOYSA-N 50514255 CHEMBL4440055 Mu-type opioid receptor Homo sapiens 627 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514255 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514255&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562502 440722837 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258265 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccncc1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-7-12-23-13-8-20)17-22(27-18)10-15-24(16-11-22)14-9-19-5-3-2-4-6-19/h2-8,12-13,18H,9-11,14-17H2,1H3 ZJJJQCGQCRZOBG-UHFFFAOYSA-N 50514269 CHEMBL4448710 Mu-type opioid receptor Homo sapiens >1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514269&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562573 440722851 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258266 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cccc(n1)C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(20-9-5-8-19(27-20)23(24,25)26)16-22(31-17)11-14-28(15-12-22)13-10-18-6-3-2-4-7-18/h2-9,17H,10-16H2,1H3 MNWMAFFICUVGRW-UHFFFAOYSA-N 50514257 CHEMBL4538620 Mu-type opioid receptor Homo sapiens 219 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514257 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514257&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567743 440722839 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258267 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cncc(F)c1 InChI=1S/C22H26FN3O2/c1-17-21(27)26(20-13-19(23)14-24-15-20)16-22(28-17)8-11-25(12-9-22)10-7-18-5-3-2-4-6-18/h2-6,13-15,17H,7-12,16H2,1H3 HJJBGZORBJLFRB-UHFFFAOYSA-N 50514239 CHEMBL4470425 Mu-type opioid receptor Homo sapiens 230 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514239 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514239&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567547 440722821 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258268 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cnccc1C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(20-15-27-11-7-19(20)23(24,25)26)16-22(31-17)9-13-28(14-10-22)12-8-18-5-3-2-4-6-18/h2-7,11,15,17H,8-10,12-14,16H2,1H3 LYDQCJJNPZBLSS-UHFFFAOYSA-N 50514270 CHEMBL4460762 Mu-type opioid receptor Homo sapiens 25 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514270 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514270&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567538 440722852 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258269 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cccnc1C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(19-8-5-12-27-20(19)23(24,25)26)16-22(31-17)10-14-28(15-11-22)13-9-18-6-3-2-4-7-18/h2-8,12,17H,9-11,13-16H2,1H3 JHFOVHVTTIYFHX-UHFFFAOYSA-N 50514240 CHEMBL4535897 Mu-type opioid receptor Homo sapiens 186 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514240&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567545 440722822 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258270 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cncc(c1)C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(20-13-19(14-27-15-20)23(24,25)26)16-22(31-17)8-11-28(12-9-22)10-7-18-5-3-2-4-6-18/h2-6,13-15,17H,7-12,16H2,1H3 BMUHJRCSESNQGV-UHFFFAOYSA-N 50514241 CHEMBL4593220 Mu-type opioid receptor Homo sapiens 721 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514241 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514241&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567534 440722823 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258271 CC1OC2(CCN(CCc3cccc(F)c3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H27FN2O2/c1-18-22(27)26(21-8-3-2-4-9-21)17-23(28-18)11-14-25(15-12-23)13-10-19-6-5-7-20(24)16-19/h2-9,16,18H,10-15,17H2,1H3 BDLPANZXJUPVDU-UHFFFAOYSA-N 50514259 CHEMBL4534193 Mu-type opioid receptor Homo sapiens 13 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514259 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514259&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562440 440722841 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258272 CC1OC2(CCN(CCc3ccccc3NC(C)=O)CC2)CN(C1=O)c1ccccc1 InChI=1S/C25H31N3O3/c1-19-24(30)28(22-9-4-3-5-10-22)18-25(31-19)13-16-27(17-14-25)15-12-21-8-6-7-11-23(21)26-20(2)29/h3-11,19H,12-18H2,1-2H3,(H,26,29) BROIIODYMJKYAW-UHFFFAOYSA-N 50514230 CHEMBL4451838 Mu-type opioid receptor Homo sapiens 342 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514230 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514230&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 126744949 440722812 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258273 CC1OC2(CCN(CCc3ccc(NC(C)=O)cc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C25H31N3O3/c1-19-24(30)28(23-6-4-3-5-7-23)18-25(31-19)13-16-27(17-14-25)15-12-21-8-10-22(11-9-21)26-20(2)29/h3-11,19H,12-18H2,1-2H3,(H,26,29) HVTXQDWADTYROW-UHFFFAOYSA-N 50514235 CHEMBL4463901 Mu-type opioid receptor Homo sapiens >1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514235 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514235&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567593 440722817 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258274 CC1OC2(CCN(CCc3cccnc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-7-3-2-4-8-20)17-22(27-18)10-14-24(15-11-22)13-9-19-6-5-12-23-16-19/h2-8,12,16,18H,9-11,13-15,17H2,1H3 VHICOZJIGXAXOC-UHFFFAOYSA-N 50514271 CHEMBL4571738 Mu-type opioid receptor Homo sapiens 853 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514271 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514271&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562372 440722853 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258275 CC1OC2(CCN(CCc3ccncc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-5-3-2-4-6-20)17-22(27-18)10-15-24(16-11-22)14-9-19-7-12-23-13-8-19/h2-8,12-13,18H,9-11,14-17H2,1H3 PIOCDECZIQSCFV-UHFFFAOYSA-N 50514260 CHEMBL4445578 Mu-type opioid receptor Homo sapiens 1424 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514260 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514260&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567672 440722842 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258276 C[C@H]1OC2(CCN(CCc3ccccc3F)CC2)CN(C1=O)c1ncccc1C(F)(F)F |r| InChI=1S/C23H25F4N3O2/c1-16-21(31)30(20-18(23(25,26)27)6-4-11-28-20)15-22(32-16)9-13-29(14-10-22)12-8-17-5-2-3-7-19(17)24/h2-7,11,16H,8-10,12-15H2,1H3 FDTFECQDLRIBOA-UHFFFAOYSA-N 50514244 CHEMBL4522004 Mu-type opioid receptor Homo sapiens 65 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514244 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514244&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567531 440722826 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258277 Fc1ccccc1CCN1CCC2(CC1)CN(C(=O)C1(CC1)O2)c1cccnc1C(F)(F)F InChI=1S/C24H25F4N3O2/c25-18-5-2-1-4-17(18)7-13-30-14-10-22(11-15-30)16-31(21(32)23(33-22)8-9-23)19-6-3-12-29-20(19)24(26,27)28/h1-6,12H,7-11,13-16H2 QNSPFRSAEHVDGL-UHFFFAOYSA-N 50514245 CHEMBL4461774 Mu-type opioid receptor Homo sapiens 195 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514245 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514245&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567543 440722827 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258278 c1cc(ccc1C(=O)CCCN2CCC(CC2)(c3ccc(cc3)Cl)O)F InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2 LNEPOXFFQSENCJ-UHFFFAOYSA-N 21398 4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1-(4-fluoro-phenyl)-butan-1-one;propionate(HCl)::Haloperidol, 1::CHEMBL545608::CHEMBL54::4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one::Haloperidol::US20240317745, Compound haloperidol Sigma non-opioid intracellular receptor 1 Homo sapiens 2.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21398 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=21398&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search GMJ 6DJZ,6LUQ,6X10 3559 49689470 CHEMBL54CHEMBL545608 DB00502 C01814 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258279 Cc1cc(OCCN2CCOCC2)nn1-c1ccc2ccccc2c1 InChI=1S/C20H23N3O2/c1-16-14-20(25-13-10-22-8-11-24-12-9-22)21-23(16)19-7-6-17-4-2-3-5-18(17)15-19/h2-7,14-15H,8-13H2,1H3 DGPGXHRHNRYVDH-UHFFFAOYSA-N 50396352 CHEMBL2170062 Sigma non-opioid intracellular receptor 1 Homo sapiens 17 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50396352 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50396352&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 44247568 163345376 CHEMBL2170062 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258280 O=C1OC2(CN1c1ccccc1)CCN(CCc1ccccc1)CC2 InChI=1S/C21H24N2O2/c24-20-23(19-9-5-2-6-10-19)17-21(25-20)12-15-22(16-13-21)14-11-18-7-3-1-4-8-18/h1-10H,11-17H2 QMZYZVGBMAHPDU-UHFFFAOYSA-N 50514246 CHEMBL4461864 Sigma non-opioid intracellular receptor 1 Homo sapiens 55 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514246 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514246&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 155528829 440722828 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258281 O=C1COC2(CCN(CCc3ccccc3)C2)CN1c1ccccc1 InChI=1S/C21H24N2O2/c24-20-15-25-21(17-23(20)19-9-5-2-6-10-19)12-14-22(16-21)13-11-18-7-3-1-4-8-18/h1-10H,11-17H2 XFVLQPBMVRXGBD-UHFFFAOYSA-N 50514229 CHEMBL4540995 Sigma non-opioid intracellular receptor 1 Homo sapiens 53 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514229 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514229&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562428 440722811 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258282 CCC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H30N2O2/c1-2-22-23(27)26(21-11-7-4-8-12-21)19-24(28-22)14-17-25(18-15-24)16-13-20-9-5-3-6-10-20/h3-12,22H,2,13-19H2,1H3 ZPNOUFCAZBAVMA-UHFFFAOYSA-N 50514248 CHEMBL4515812 Sigma non-opioid intracellular receptor 1 Homo sapiens 6.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514248&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562510 440722830 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258283 CC(C)C1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C25H32N2O2/c1-20(2)23-24(28)27(22-11-7-4-8-12-22)19-25(29-23)14-17-26(18-15-25)16-13-21-9-5-3-6-10-21/h3-12,20,23H,13-19H2,1-2H3 TZGRGSUVKBRDCV-UHFFFAOYSA-N 50514249 CHEMBL4436170 Sigma non-opioid intracellular receptor 1 Homo sapiens 10.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514249&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562375 440722831 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258284 COCC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H30N2O3/c1-28-18-22-23(27)26(21-10-6-3-7-11-21)19-24(29-22)13-16-25(17-14-24)15-12-20-8-4-2-5-9-20/h2-11,22H,12-19H2,1H3 CAXQLHIXVZVOAJ-UHFFFAOYSA-N 50514265 CHEMBL4439285 Sigma non-opioid intracellular receptor 1 Homo sapiens 32 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514265 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514265&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567313 440722847 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258285 O=C1C(COCc2ccccc2)OC2(CCN(CCc3ccccc3)CC2)CN1c1ccccc1 InChI=1S/C30H34N2O3/c33-29-28(23-34-22-26-12-6-2-7-13-26)35-30(24-32(29)27-14-8-3-9-15-27)17-20-31(21-18-30)19-16-25-10-4-1-5-11-25/h1-15,28H,16-24H2 OCSZOZIYXZJENV-UHFFFAOYSA-N 50514272 CHEMBL4528962 Sigma non-opioid intracellular receptor 1 Homo sapiens 40 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514272 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514272&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562576 440722854 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258286 CC1(C)OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H30N2O2/c1-23(2)22(27)26(21-11-7-4-8-12-21)19-24(28-23)14-17-25(18-15-24)16-13-20-9-5-3-6-10-20/h3-12H,13-19H2,1-2H3 FVBRGBXYCPMCNB-UHFFFAOYSA-N 50514273 CHEMBL4516327 Sigma non-opioid intracellular receptor 1 Homo sapiens 13 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514273 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514273&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562606 440722855 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258287 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1Cl InChI=1S/C23H27ClN2O2/c1-18-22(27)26(21-10-6-5-9-20(21)24)17-23(28-18)12-15-25(16-13-23)14-11-19-7-3-2-4-8-19/h2-10,18H,11-17H2,1H3 BLXCYXQUSIEXTF-UHFFFAOYSA-N 50514252 CHEMBL4452042 Sigma non-opioid intracellular receptor 1 Homo sapiens 8.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514252&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567608 440722834 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258288 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1F InChI=1S/C23H27FN2O2/c1-18-22(27)26(21-10-6-5-9-20(21)24)17-23(28-18)12-15-25(16-13-23)14-11-19-7-3-2-4-8-19/h2-10,18H,11-17H2,1H3 LBUMRHRNIHWDBD-UHFFFAOYSA-N 50514253 CHEMBL4584335 Sigma non-opioid intracellular receptor 1 Homo sapiens 11 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514253&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567604 440722835 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258289 COc1ccccc1N1CC2(CCN(CCc3ccccc3)CC2)OC(C)C1=O InChI=1S/C24H30N2O3/c1-19-23(27)26(21-10-6-7-11-22(21)28-2)18-24(29-19)13-16-25(17-14-24)15-12-20-8-4-3-5-9-20/h3-11,19H,12-18H2,1-2H3 SKDFRXDSPIOUSP-UHFFFAOYSA-N 50514267 CHEMBL4526087 Sigma non-opioid intracellular receptor 1 Homo sapiens 38 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514267 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514267&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567744 440722849 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258290 COc1cccc(c1)N1CC2(CCN(CCc3ccccc3)CC2)OC(C)C1=O InChI=1S/C24H30N2O3/c1-19-23(27)26(21-9-6-10-22(17-21)28-2)18-24(29-19)12-15-25(16-13-24)14-11-20-7-4-3-5-8-20/h3-10,17,19H,11-16,18H2,1-2H3 ZEIMIZKOLIBIEH-UHFFFAOYSA-N 50514227 CHEMBL4550656 Sigma non-opioid intracellular receptor 1 Homo sapiens 15 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514227 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514227&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562556 440722809 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258291 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cccnc1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-8-5-12-23-16-20)17-22(27-18)10-14-24(15-11-22)13-9-19-6-3-2-4-7-19/h2-8,12,16,18H,9-11,13-15,17H2,1H3 XMHDSSGOIGKARI-UHFFFAOYSA-N 50514255 CHEMBL4440055 Sigma non-opioid intracellular receptor 1 Homo sapiens 68 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514255 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514255&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562502 440722837 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258292 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cnccn1 InChI=1S/C21H26N4O2/c1-17-20(26)25(19-15-22-10-11-23-19)16-21(27-17)8-13-24(14-9-21)12-7-18-5-3-2-4-6-18/h2-6,10-11,15,17H,7-9,12-14,16H2,1H3 PFSGEFYLEHABKV-UHFFFAOYSA-N 50514256 CHEMBL4439718 Sigma non-opioid intracellular receptor 1 Homo sapiens 13 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514256&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567605 440722838 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258293 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cccc(n1)C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(20-9-5-8-19(27-20)23(24,25)26)16-22(31-17)11-14-28(15-12-22)13-10-18-6-3-2-4-7-18/h2-9,17H,10-16H2,1H3 MNWMAFFICUVGRW-UHFFFAOYSA-N 50514257 CHEMBL4538620 Sigma non-opioid intracellular receptor 1 Homo sapiens 8.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514257 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514257&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567743 440722839 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258294 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ncccc1C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(20-19(23(24,25)26)8-5-12-27-20)16-22(31-17)10-14-28(15-11-22)13-9-18-6-3-2-4-7-18/h2-8,12,17H,9-11,13-16H2,1H3 QVSZFVNYJYNUGG-UHFFFAOYSA-N 50514228 CHEMBL4448670 Sigma non-opioid intracellular receptor 1 Homo sapiens 54 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514228 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514228&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562402 440722810 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258295 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cnccc1C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(20-15-27-11-7-19(20)23(24,25)26)16-22(31-17)9-13-28(14-10-22)12-8-18-5-3-2-4-6-18/h2-7,11,15,17H,8-10,12-14,16H2,1H3 LYDQCJJNPZBLSS-UHFFFAOYSA-N 50514270 CHEMBL4460762 Sigma non-opioid intracellular receptor 1 Homo sapiens 63 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514270 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514270&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567538 440722852 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258296 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cncc(c1)C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(20-13-19(14-27-15-20)23(24,25)26)16-22(31-17)8-11-28(12-9-22)10-7-18-5-3-2-4-6-18/h2-6,13-15,17H,7-12,16H2,1H3 BMUHJRCSESNQGV-UHFFFAOYSA-N 50514241 CHEMBL4593220 Sigma non-opioid intracellular receptor 1 Homo sapiens 14 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514241 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514241&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567534 440722823 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258297 CC1OC2(CCN(CCc3ccccc3F)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H27FN2O2/c1-18-22(27)26(20-8-3-2-4-9-20)17-23(28-18)12-15-25(16-13-23)14-11-19-7-5-6-10-21(19)24/h2-10,18H,11-17H2,1H3 ZAIUBAOMYCTCCK-UHFFFAOYSA-N 50514232 CHEMBL4536259 Sigma non-opioid intracellular receptor 1 Homo sapiens 8.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514232&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562384 440722814 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258298 CC1OC2(CCN(CCc3cccc(F)c3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H27FN2O2/c1-18-22(27)26(21-8-3-2-4-9-21)17-23(28-18)11-14-25(15-12-23)13-10-19-6-5-7-20(24)16-19/h2-9,16,18H,10-15,17H2,1H3 BDLPANZXJUPVDU-UHFFFAOYSA-N 50514259 CHEMBL4534193 Sigma non-opioid intracellular receptor 1 Homo sapiens 8.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514259 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514259&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562440 440722841 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258299 CC1OC2(CCN(CCc3cccc(c3)C#N)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H27N3O2/c1-19-23(28)27(22-8-3-2-4-9-22)18-24(29-19)11-14-26(15-12-24)13-10-20-6-5-7-21(16-20)17-25/h2-9,16,19H,10-15,18H2,1H3 ORXZYLUNARJXOL-UHFFFAOYSA-N 50514243 CHEMBL4463621 Sigma non-opioid intracellular receptor 1 Homo sapiens 28 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514243&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562359 440722825 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258300 CC1OC2(CCN(CCc3ccccn3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-8-3-2-4-9-20)17-22(27-18)11-15-24(16-12-22)14-10-19-7-5-6-13-23-19/h2-9,13,18H,10-12,14-17H2,1H3 QPMLJPMWNURBDC-UHFFFAOYSA-N 50514274 CHEMBL4473746 Sigma non-opioid intracellular receptor 1 Homo sapiens 53 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514274 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514274&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562598 440722856 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258301 CC1OC2(CCN(CCc3ccncc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-5-3-2-4-6-20)17-22(27-18)10-15-24(16-11-22)14-9-19-7-12-23-13-8-19/h2-8,12-13,18H,9-11,14-17H2,1H3 PIOCDECZIQSCFV-UHFFFAOYSA-N 50514260 CHEMBL4445578 Sigma non-opioid intracellular receptor 1 Homo sapiens 112 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514260 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514260&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567672 440722842 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258302 CC1OC2(CCN(CCc3ccccn3)CC2)CN(C1=O)c1cnccc1C(F)(F)F InChI=1S/C22H25F3N4O2/c1-16-20(30)29(19-14-26-10-5-18(19)22(23,24)25)15-21(31-16)7-12-28(13-8-21)11-6-17-4-2-3-9-27-17/h2-5,9-10,14,16H,6-8,11-13,15H2,1H3 DBYOLMQXHPITEO-UHFFFAOYSA-N 50514261 CHEMBL4540888 Sigma non-opioid intracellular receptor 1 Homo sapiens 622 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514261 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514261&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567689 440722843 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258303 C[C@H]1OC2(CCN(CCc3ccccc3F)CC2)CN(C1=O)c1cnccc1C(F)(F)F |r| InChI=1S/C23H25F4N3O2/c1-16-21(31)30(20-14-28-10-6-18(20)23(25,26)27)15-22(32-16)8-12-29(13-9-22)11-7-17-4-2-3-5-19(17)24/h2-6,10,14,16H,7-9,11-13,15H2,1H3 INCPDVXLHDEOLM-UHFFFAOYSA-N 50514262 CHEMBL4576031 Sigma non-opioid intracellular receptor 1 Homo sapiens 61 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514262 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514262&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 126744972 440722844 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258304 Fc1ccccc1CCN1CCC2(CC1)CN(C(=O)C1(CC1)O2)c1cccnc1C(F)(F)F InChI=1S/C24H25F4N3O2/c25-18-5-2-1-4-17(18)7-13-30-14-10-22(11-15-30)16-31(21(32)23(33-22)8-9-23)19-6-3-12-29-20(19)24(26,27)28/h1-6,12H,7-11,13-16H2 QNSPFRSAEHVDGL-UHFFFAOYSA-N 50514245 CHEMBL4461774 Sigma non-opioid intracellular receptor 1 Homo sapiens 58 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514245 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514245&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567543 440722827 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258305 C[C@@H]1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 |r| InChI=1S/C23H28N2O2/c1-19-22(26)25(21-10-6-3-7-11-21)18-23(27-19)13-16-24(17-14-23)15-12-20-8-4-2-5-9-20/h2-11,19H,12-18H2,1H3 RSVBTLSIVBWMNF-UHFFFAOYSA-N 50514264 CHEMBL4467749 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 300 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514264 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514264&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118562451 440722846 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258306 CC(C)C1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C25H32N2O2/c1-20(2)23-24(28)27(22-11-7-4-8-12-22)19-25(29-23)14-17-26(18-15-25)16-13-21-9-5-3-6-10-21/h3-12,20,23H,13-19H2,1-2H3 TZGRGSUVKBRDCV-UHFFFAOYSA-N 50514249 CHEMBL4436170 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1200 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514249&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118562375 440722831 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258307 COCC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H30N2O3/c1-28-18-22-23(27)26(21-10-6-3-7-11-21)19-24(29-22)13-16-25(17-14-24)15-12-20-8-4-2-5-9-20/h2-11,22H,12-19H2,1H3 CAXQLHIXVZVOAJ-UHFFFAOYSA-N 50514265 CHEMBL4439285 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1900 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514265 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514265&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118567313 440722847 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258308 OCC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H28N2O3/c26-17-21-22(27)25(20-9-5-2-6-10-20)18-23(28-21)12-15-24(16-13-23)14-11-19-7-3-1-4-8-19/h1-10,21,26H,11-18H2 QGQRUYNHBMRUGE-UHFFFAOYSA-N 50514266 CHEMBL4459117 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1100 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514266 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514266&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118562362 440722848 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258309 CC1(C)OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H30N2O2/c1-23(2)22(27)26(21-11-7-4-8-12-21)19-24(28-23)14-17-25(18-15-24)16-13-20-9-5-3-6-10-20/h3-12H,13-19H2,1-2H3 FVBRGBXYCPMCNB-UHFFFAOYSA-N 50514273 CHEMBL4516327 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 100 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514273 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514273&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118562606 440722855 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258310 O=C1N(CC2(CCN(CCc3ccccc3)CC2)OC11CC1)c1ccccc1 InChI=1S/C24H28N2O2/c27-22-24(12-13-24)28-23(19-26(22)21-9-5-2-6-10-21)14-17-25(18-15-23)16-11-20-7-3-1-4-8-20/h1-10H,11-19H2 ZCMSPFVAMUOJIK-UHFFFAOYSA-N 50514251 CHEMBL4438550 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1200 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514251&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118562538 440722833 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258311 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1Cl InChI=1S/C23H27ClN2O2/c1-18-22(27)26(21-10-6-5-9-20(21)24)17-23(28-18)12-15-25(16-13-23)14-11-19-7-3-2-4-8-19/h2-10,18H,11-17H2,1H3 BLXCYXQUSIEXTF-UHFFFAOYSA-N 50514252 CHEMBL4452042 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514252&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118567608 440722834 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258312 O=C1COC2(CCN(Cc3ccccc3)CC2)CN1c1ccccc1 InChI=1S/C21H24N2O2/c24-20-16-25-21(17-23(20)19-9-5-2-6-10-19)11-13-22(14-12-21)15-18-7-3-1-4-8-18/h1-10H,11-17H2 KBEJBFGBZGNZHJ-UHFFFAOYSA-N 50514263 CHEMBL4446292 Mu-type opioid receptor Homo sapiens 534 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514263 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514263&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567654 440722845 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258313 C[C@@H]1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 |r| InChI=1S/C23H28N2O2/c1-19-22(26)25(21-10-6-3-7-11-21)18-23(27-19)13-16-24(17-14-23)15-12-20-8-4-2-5-9-20/h2-11,19H,12-18H2,1H3 RSVBTLSIVBWMNF-UHFFFAOYSA-N 50514264 CHEMBL4467749 Mu-type opioid receptor Homo sapiens 69 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514264 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514264&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562451 440722846 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258314 COCC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H30N2O3/c1-28-18-22-23(27)26(21-10-6-3-7-11-21)19-24(29-22)13-16-25(17-14-24)15-12-20-8-4-2-5-9-20/h2-11,22H,12-19H2,1H3 CAXQLHIXVZVOAJ-UHFFFAOYSA-N 50514265 CHEMBL4439285 Mu-type opioid receptor Homo sapiens 13 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514265 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514265&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567313 440722847 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258315 CC1(C)OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H30N2O2/c1-23(2)22(27)26(21-11-7-4-8-12-21)19-24(28-23)14-17-25(18-15-24)16-13-20-9-5-3-6-10-20/h3-12H,13-19H2,1-2H3 FVBRGBXYCPMCNB-UHFFFAOYSA-N 50514273 CHEMBL4516327 Mu-type opioid receptor Homo sapiens 3.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514273 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514273&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562606 440722855 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258316 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1O InChI=1S/C23H28N2O3/c1-18-22(27)25(20-9-5-6-10-21(20)26)17-23(28-18)12-15-24(16-13-23)14-11-19-7-3-2-4-8-19/h2-10,18,26H,11-17H2,1H3 RHMYPZYXJBYMPC-UHFFFAOYSA-N 50514275 CHEMBL4592081 Mu-type opioid receptor Homo sapiens 535 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514275 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514275&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567618 440722857 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258317 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccn1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-9-5-6-13-23-20)17-22(27-18)11-15-24(16-12-22)14-10-19-7-3-2-4-8-19/h2-9,13,18H,10-12,14-17H2,1H3 XFDIYQRODQBNBJ-UHFFFAOYSA-N 50514268 CHEMBL4578955 Mu-type opioid receptor Homo sapiens 930 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514268 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514268&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567606 440722850 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258318 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ncccc1F InChI=1S/C22H26FN3O2/c1-17-21(27)26(20-19(23)8-5-12-24-20)16-22(28-17)10-14-25(15-11-22)13-9-18-6-3-2-4-7-18/h2-8,12,17H,9-11,13-16H2,1H3 JHDWAFRPXSZUKN-UHFFFAOYSA-N 50514236 CHEMBL4483643 Mu-type opioid receptor Homo sapiens 93 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514236 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514236&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567747 440722818 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258319 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cnccc1C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(20-15-27-11-7-19(20)23(24,25)26)16-22(31-17)9-13-28(14-10-22)12-8-18-5-3-2-4-6-18/h2-7,11,15,17H,8-10,12-14,16H2,1H3 LYDQCJJNPZBLSS-UHFFFAOYSA-N 50514270 CHEMBL4460762 Mu-type opioid receptor Homo sapiens 28 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514270 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514270&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567538 440722852 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258320 CC1OC2(CCN(CCc3ccccn3)CC2)CN(C1=O)c1cnccc1C(F)(F)F InChI=1S/C22H25F3N4O2/c1-16-20(30)29(19-14-26-10-5-18(19)22(23,24)25)15-21(31-16)7-12-28(13-8-21)11-6-17-4-2-3-9-27-17/h2-5,9-10,14,16H,6-8,11-13,15H2,1H3 DBYOLMQXHPITEO-UHFFFAOYSA-N 50514261 CHEMBL4540888 Mu-type opioid receptor Homo sapiens 767 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514261 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514261&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567689 440722843 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258321 O=C1COC2(CCN(CCc3ccccc3)CC2)CN1c1ccccc1 InChI=1S/C22H26N2O2/c25-21-17-26-22(18-24(21)20-9-5-2-6-10-20)12-15-23(16-13-22)14-11-19-7-3-1-4-8-19/h1-10H,11-18H2 DHIDSSXNRVGMDP-UHFFFAOYSA-N 50514276 CHEMBL4439908 Sigma non-opioid intracellular receptor 1 Homo sapiens 57 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514276 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514276&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567670 440722858 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258322 C[C@@H]1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 |r| InChI=1S/C23H28N2O2/c1-19-22(26)25(21-10-6-3-7-11-21)18-23(27-19)13-16-24(17-14-23)15-12-20-8-4-2-5-9-20/h2-11,19H,12-18H2,1H3 RSVBTLSIVBWMNF-UHFFFAOYSA-N 50514264 CHEMBL4467749 Sigma non-opioid intracellular receptor 1 Homo sapiens 14 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514264 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514264&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562451 440722846 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258323 OCC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H28N2O3/c26-17-21-22(27)25(20-9-5-2-6-10-20)18-23(28-21)12-15-24(16-13-23)14-11-19-7-3-1-4-8-19/h1-10,21,26H,11-18H2 QGQRUYNHBMRUGE-UHFFFAOYSA-N 50514266 CHEMBL4459117 Sigma non-opioid intracellular receptor 1 Homo sapiens 209 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514266 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514266&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562362 440722848 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258324 O=C1N(CC2(CCN(CCc3ccccc3)CC2)OC11CC1)c1ccccc1 InChI=1S/C24H28N2O2/c27-22-24(12-13-24)28-23(19-26(22)21-9-5-2-6-10-21)14-17-25(18-15-23)16-11-20-7-3-1-4-8-20/h1-10H,11-19H2 ZCMSPFVAMUOJIK-UHFFFAOYSA-N 50514251 CHEMBL4438550 Sigma non-opioid intracellular receptor 1 Homo sapiens 9.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514251&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562538 440722833 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258325 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1O InChI=1S/C23H28N2O3/c1-18-22(27)25(20-9-5-6-10-21(20)26)17-23(28-18)12-15-24(16-13-23)14-11-19-7-3-2-4-8-19/h2-10,18,26H,11-17H2,1H3 RHMYPZYXJBYMPC-UHFFFAOYSA-N 50514275 CHEMBL4592081 Sigma non-opioid intracellular receptor 1 Homo sapiens 51 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514275 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514275&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567618 440722857 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258326 CC1OC2(CCN(CCc3cccc(NC(C)=O)c3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C25H31N3O3/c1-19-24(30)28(23-9-4-3-5-10-23)18-25(31-19)12-15-27(16-13-25)14-11-21-7-6-8-22(17-21)26-20(2)29/h3-10,17,19H,11-16,18H2,1-2H3,(H,26,29) GFMRIFXLIUPAFX-UHFFFAOYSA-N 50514242 CHEMBL4573960 Mu-type opioid receptor Homo sapiens 144 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514242 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514242&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 126744800 440722824 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258327 CC1OC2(CCN(CCc3cccnc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-7-3-2-4-8-20)17-22(27-18)10-14-24(15-11-22)13-9-19-6-5-12-23-16-19/h2-8,12,16,18H,9-11,13-15,17H2,1H3 VHICOZJIGXAXOC-UHFFFAOYSA-N 50514271 CHEMBL4571738 Mu-type opioid receptor Homo sapiens 117 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514271 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514271&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562372 440722853 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258328 Fc1ccccc1CCN1CCC2(CC1)CN(C(=O)C1(CC1)O2)c1cccnc1C(F)(F)F InChI=1S/C24H25F4N3O2/c25-18-5-2-1-4-17(18)7-13-30-14-10-22(11-15-30)16-31(21(32)23(33-22)8-9-23)19-6-3-12-29-20(19)24(26,27)28/h1-6,12H,7-11,13-16H2 QNSPFRSAEHVDGL-UHFFFAOYSA-N 50514245 CHEMBL4461774 Mu-type opioid receptor Homo sapiens 175 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514245 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514245&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567543 440722827 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258329 c1cc(ccc1C(=O)CCCN2CCC(CC2)(c3ccc(cc3)Cl)O)F InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2 LNEPOXFFQSENCJ-UHFFFAOYSA-N 21398 4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1-(4-fluoro-phenyl)-butan-1-one;propionate(HCl)::Haloperidol, 1::CHEMBL545608::CHEMBL54::4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one::Haloperidol::US20240317745, Compound haloperidol Mu-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21398 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=21398&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search GMJ 6DJZ,6LUQ,6X10 3559 49689470 CHEMBL54CHEMBL545608 DB00502 C01814 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258330 O=C1COC2(CCN(CCc3ccccc3)CC2)CN1c1ccccc1 InChI=1S/C22H26N2O2/c25-21-17-26-22(18-24(21)20-9-5-2-6-10-20)12-15-23(16-13-22)14-11-19-7-3-1-4-8-19/h1-10H,11-18H2 DHIDSSXNRVGMDP-UHFFFAOYSA-N 50514276 CHEMBL4439908 Mu-type opioid receptor Homo sapiens 523 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514276 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514276&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567670 440722858 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258331 C[C@H]1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 |r| InChI=1S/C23H28N2O2/c1-19-22(26)25(21-10-6-3-7-11-21)18-23(27-19)13-16-24(17-14-23)15-12-20-8-4-2-5-9-20/h2-11,19H,12-18H2,1H3 RSVBTLSIVBWMNF-UHFFFAOYSA-N 50514247 CHEMBL4450665 Mu-type opioid receptor Homo sapiens 16 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514247&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562584 440722829 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258332 O=C1C(COCc2ccccc2)OC2(CCN(CCc3ccccc3)CC2)CN1c1ccccc1 InChI=1S/C30H34N2O3/c33-29-28(23-34-22-26-12-6-2-7-13-26)35-30(24-32(29)27-14-8-3-9-15-27)17-20-31(21-18-30)19-16-25-10-4-1-5-11-25/h1-15,28H,16-24H2 OCSZOZIYXZJENV-UHFFFAOYSA-N 50514272 CHEMBL4528962 Mu-type opioid receptor Homo sapiens 107 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514272 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514272&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562576 440722854 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258333 CC1(C)OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H30N2O2/c1-23(2)22(27)26(21-11-7-4-8-12-21)19-24(28-23)14-17-25(18-15-24)16-13-20-9-5-3-6-10-20/h3-12H,13-19H2,1-2H3 FVBRGBXYCPMCNB-UHFFFAOYSA-N 50514273 CHEMBL4516327 Mu-type opioid receptor Homo sapiens 4.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514273 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514273&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562606 440722855 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258334 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1O InChI=1S/C23H28N2O3/c1-18-22(27)25(20-9-5-6-10-21(20)26)17-23(28-18)12-15-24(16-13-23)14-11-19-7-3-2-4-8-19/h2-10,18,26H,11-17H2,1H3 RHMYPZYXJBYMPC-UHFFFAOYSA-N 50514275 CHEMBL4592081 Mu-type opioid receptor Homo sapiens >1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514275 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514275&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567618 440722857 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258335 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccc(O)cc1 InChI=1S/C23H28N2O3/c1-18-22(27)25(20-7-9-21(26)10-8-20)17-23(28-18)12-15-24(16-13-23)14-11-19-5-3-2-4-6-19/h2-10,18,26H,11-17H2,1H3 HEVHIURIMIMQGN-UHFFFAOYSA-N 50514277 CHEMBL4513933 Mu-type opioid receptor Homo sapiens >1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514277 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514277&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567550 440722859 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258336 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cnccn1 InChI=1S/C21H26N4O2/c1-17-20(26)25(19-15-22-10-11-23-19)16-21(27-17)8-13-24(14-9-21)12-7-18-5-3-2-4-6-18/h2-6,10-11,15,17H,7-9,12-14,16H2,1H3 PFSGEFYLEHABKV-UHFFFAOYSA-N 50514256 CHEMBL4439718 Mu-type opioid receptor Homo sapiens 527 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514256&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567605 440722838 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258337 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccc(nc1)C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(19-7-8-20(27-15-19)23(24,25)26)16-22(31-17)10-13-28(14-11-22)12-9-18-5-3-2-4-6-18/h2-8,15,17H,9-14,16H2,1H3 SBBYFXIXMFNMNQ-UHFFFAOYSA-N 50514258 CHEMBL4560624 Mu-type opioid receptor Homo sapiens >1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514258&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567742 440722840 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258338 CC1OC2(CCN(CCc3ccccc3F)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H27FN2O2/c1-18-22(27)26(20-8-3-2-4-9-20)17-23(28-18)12-15-25(16-13-23)14-11-19-7-5-6-10-21(19)24/h2-10,18H,11-17H2,1H3 ZAIUBAOMYCTCCK-UHFFFAOYSA-N 50514232 CHEMBL4536259 Mu-type opioid receptor Homo sapiens 4.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514232&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562384 440722814 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258339 CC1OC2(CCN(CCc3ccccn3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-8-3-2-4-9-20)17-22(27-18)11-15-24(16-12-22)14-10-19-7-5-6-13-23-19/h2-9,13,18H,10-12,14-17H2,1H3 QPMLJPMWNURBDC-UHFFFAOYSA-N 50514274 CHEMBL4473746 Mu-type opioid receptor Homo sapiens 229 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514274 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514274&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562598 440722856 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258340 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccn1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-9-5-6-13-23-20)17-22(27-18)11-15-24(16-12-22)14-10-19-7-3-2-4-8-19/h2-9,13,18H,10-12,14-17H2,1H3 XFDIYQRODQBNBJ-UHFFFAOYSA-N 50514268 CHEMBL4578955 Sigma non-opioid intracellular receptor 1 Homo sapiens 13 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514268 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514268&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567606 440722850 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258341 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ncccc1F InChI=1S/C22H26FN3O2/c1-17-21(27)26(20-19(23)8-5-12-24-20)16-22(28-17)10-14-25(15-11-22)13-9-18-6-3-2-4-7-18/h2-8,12,17H,9-11,13-16H2,1H3 JHDWAFRPXSZUKN-UHFFFAOYSA-N 50514236 CHEMBL4483643 Sigma non-opioid intracellular receptor 1 Homo sapiens 39 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514236 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514236&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567747 440722818 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258342 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cccnc1C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(19-8-5-12-27-20(19)23(24,25)26)16-22(31-17)10-14-28(15-11-22)13-9-18-6-3-2-4-7-18/h2-8,12,17H,9-11,13-16H2,1H3 JHFOVHVTTIYFHX-UHFFFAOYSA-N 50514240 CHEMBL4535897 Sigma non-opioid intracellular receptor 1 Homo sapiens 48 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514240&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567545 440722822 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258343 CC1OC2(CCN(CCc3ccccc3NC(C)=O)CC2)CN(C1=O)c1ccccc1 InChI=1S/C25H31N3O3/c1-19-24(30)28(22-9-4-3-5-10-22)18-25(31-19)13-16-27(17-14-25)15-12-21-8-6-7-11-23(21)26-20(2)29/h3-11,19H,12-18H2,1-2H3,(H,26,29) BROIIODYMJKYAW-UHFFFAOYSA-N 50514230 CHEMBL4451838 Sigma non-opioid intracellular receptor 1 Homo sapiens 656 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514230 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514230&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 126744949 440722812 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258344 CC1OC2(CCN(CCc3cccnc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-7-3-2-4-8-20)17-22(27-18)10-14-24(15-11-22)13-9-19-6-5-12-23-16-19/h2-8,12,16,18H,9-11,13-15,17H2,1H3 VHICOZJIGXAXOC-UHFFFAOYSA-N 50514271 CHEMBL4571738 Sigma non-opioid intracellular receptor 1 Homo sapiens 91 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514271 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514271&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562372 440722853 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258345 C[C@H]1OC2(CCN(CCc3ccccc3F)CC2)CN(C1=O)c1ncccc1C(F)(F)F |r| InChI=1S/C23H25F4N3O2/c1-16-21(31)30(20-18(23(25,26)27)6-4-11-28-20)15-22(32-16)9-13-29(14-10-22)12-8-17-5-2-3-7-19(17)24/h2-7,11,16H,8-10,12-15H2,1H3 FDTFECQDLRIBOA-UHFFFAOYSA-N 50514244 CHEMBL4522004 Sigma non-opioid intracellular receptor 1 Homo sapiens 103 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514244 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514244&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567531 440722826 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258346 C[C@H]1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 |r| InChI=1S/C23H28N2O2/c1-19-22(26)25(21-10-6-3-7-11-21)18-23(27-19)13-16-24(17-14-23)15-12-20-8-4-2-5-9-20/h2-11,19H,12-18H2,1H3 RSVBTLSIVBWMNF-UHFFFAOYSA-N 50514247 CHEMBL4450665 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1200 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514247&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118562584 440722829 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258347 O=C1C(COCc2ccccc2)OC2(CCN(CCc3ccccc3)CC2)CN1c1ccccc1 InChI=1S/C30H34N2O3/c33-29-28(23-34-22-26-12-6-2-7-13-26)35-30(24-32(29)27-14-8-3-9-15-27)17-20-31(21-18-30)19-16-25-10-4-1-5-11-25/h1-15,28H,16-24H2 OCSZOZIYXZJENV-UHFFFAOYSA-N 50514272 CHEMBL4528962 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 100 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514272 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514272&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118562576 440722854 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258348 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1F InChI=1S/C23H27FN2O2/c1-18-22(27)26(21-10-6-5-9-20(21)24)17-23(28-18)12-15-25(16-13-23)14-11-19-7-3-2-4-8-19/h2-10,18H,11-17H2,1H3 LBUMRHRNIHWDBD-UHFFFAOYSA-N 50514253 CHEMBL4584335 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1200 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514253&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118567604 440722835 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258349 C[C@H]1OC2(CCN(CCc3ccccc3F)CC2)CN(C1=O)c1ncccc1C(F)(F)F |r| InChI=1S/C23H25F4N3O2/c1-16-21(31)30(20-18(23(25,26)27)6-4-11-28-20)15-22(32-16)9-13-29(14-10-22)12-8-17-5-2-3-7-19(17)24/h2-7,11,16H,8-10,12-15H2,1H3 FDTFECQDLRIBOA-UHFFFAOYSA-N 50514244 CHEMBL4522004 Mu-type opioid receptor Homo sapiens 34 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514244 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514244&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567531 440722826 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258350 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1F InChI=1S/C23H27FN2O2/c1-18-22(27)26(21-10-6-5-9-20(21)24)17-23(28-18)12-15-25(16-13-23)14-11-19-7-3-2-4-8-19/h2-10,18H,11-17H2,1H3 LBUMRHRNIHWDBD-UHFFFAOYSA-N 50514253 CHEMBL4584335 Mu-type opioid receptor Homo sapiens 4.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514253&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567604 440722835 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258351 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ncccc1C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(20-19(23(24,25)26)8-5-12-27-20)16-22(31-17)10-14-28(15-11-22)13-9-18-6-3-2-4-7-18/h2-8,12,17H,9-11,13-16H2,1H3 QVSZFVNYJYNUGG-UHFFFAOYSA-N 50514228 CHEMBL4448670 Mu-type opioid receptor Homo sapiens 343 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514228 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514228&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562402 440722810 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258352 CC1OC2(CCN(CCc3cccc(c3)C#N)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H27N3O2/c1-19-23(28)27(22-8-3-2-4-9-22)18-24(29-19)11-14-26(15-12-24)13-10-20-6-5-7-21(16-20)17-25/h2-9,16,19H,10-15,18H2,1H3 ORXZYLUNARJXOL-UHFFFAOYSA-N 50514243 CHEMBL4463621 Mu-type opioid receptor Homo sapiens 61 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514243&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562359 440722825 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258353 COC(=O)CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C25H30N2O4/c1-30-23(28)18-22-24(29)27(21-10-6-3-7-11-21)19-25(31-22)13-16-26(17-14-25)15-12-20-8-4-2-5-9-20/h2-11,22H,12-19H2,1H3 NWICMXBOJMLOIB-UHFFFAOYSA-N 50514226 CHEMBL4446209 Sigma non-opioid intracellular receptor 1 Homo sapiens 54 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514226&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562469 440722808 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258354 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccncc1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-7-12-23-13-8-20)17-22(27-18)10-15-24(16-11-22)14-9-19-5-3-2-4-6-19/h2-8,12-13,18H,9-11,14-17H2,1H3 ZJJJQCGQCRZOBG-UHFFFAOYSA-N 50514269 CHEMBL4448710 Sigma non-opioid intracellular receptor 1 Homo sapiens 88 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514269&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562573 440722851 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258355 CC1OC2(CCN(CCc3ccc(F)cc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H27FN2O2/c1-18-22(27)26(21-5-3-2-4-6-21)17-23(28-18)12-15-25(16-13-23)14-11-19-7-9-20(24)10-8-19/h2-10,18H,11-17H2,1H3 APZHXGIRWMPKDR-UHFFFAOYSA-N 50514233 CHEMBL4544352 Sigma non-opioid intracellular receptor 1 Homo sapiens 11 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514233 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514233&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562567 440722815 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258356 COC(=O)CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C25H30N2O4/c1-30-23(28)18-22-24(29)27(21-10-6-3-7-11-21)19-25(31-22)13-16-26(17-14-25)15-12-20-8-4-2-5-9-20/h2-11,22H,12-19H2,1H3 NWICMXBOJMLOIB-UHFFFAOYSA-N 50514226 CHEMBL4446209 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 200 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514226&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118562469 440722808 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258357 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cnccn1 InChI=1S/C21H26N4O2/c1-17-20(26)25(19-15-22-10-11-23-19)16-21(27-17)8-13-24(14-9-21)12-7-18-5-3-2-4-6-18/h2-6,10-11,15,17H,7-9,12-14,16H2,1H3 PFSGEFYLEHABKV-UHFFFAOYSA-N 50514256 CHEMBL4439718 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 100 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514256&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118567605 440722838 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258358 CC1OC2(CCN(CCc3ccccn3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-8-3-2-4-9-20)17-22(27-18)11-15-24(16-12-22)14-10-19-7-5-6-13-23-19/h2-9,13,18H,10-12,14-17H2,1H3 QPMLJPMWNURBDC-UHFFFAOYSA-N 50514274 CHEMBL4473746 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 2000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514274 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514274&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118562598 440722856 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258359 Fc1ccccc1CCN1CCC2(CC1)CN(C(=O)C1(CC1)O2)c1cccnc1C(F)(F)F InChI=1S/C24H25F4N3O2/c25-18-5-2-1-4-17(18)7-13-30-14-10-22(11-15-30)16-31(21(32)23(33-22)8-9-23)19-6-3-12-29-20(19)24(26,27)28/h1-6,12H,7-11,13-16H2 QNSPFRSAEHVDGL-UHFFFAOYSA-N 50514245 CHEMBL4461774 5-hydroxytryptamine receptor 2B Homo sapiens 754 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514245 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3429&target=5-hydroxytryptamine+receptor+2B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514245&enzyme=5-hydroxytryptamine+receptor+2B&column=ki&startPg=0&Increment=50&submit=Search 118567543 440722827 1 MALSYRVSELQSTIPEHILQSTFVHVISSNWSGLQTESIPEEMKQIVEEQGNKLHWAALLILMVIIPTIGGNTLVILAVSLEKKLQYATNYFLMSLAVADLLVGLFVMPIALLTIMFEAMWPLPLVLCPAWLFLDVLFSTASIMHLCAISVDRYIAIKKPIQANQYNSRATAFIKITVVWLISIGIAIPVPIKGIETDVDNPNNITCVLTKERFGDFMLFGSLAAFFTPLAIMIVTYFLTIHALQKKAYLVKNKPPQRLTWLTVSTVFQRDETPCSSPEKVAMLDGSRKDKALPNSGDETLMRRTSTIGKKSVQTISNEQRASKVLGIVFFLFLLMWCPFFITNITLVLCDSCNQTTLQMLLEIFVWIGYVSSGVNPLVYTLFNKTFRDAFGRYITCNYRATKSVKTLRKRSSKIYFRNPMAENSKFFKKHGIRNGINPAMYQSPMRLRSSTIQSSSIILLDTLLLTENEGDKTEEQVSYV 5-hydroxytryptamine receptor 2B 5HT2B_HUMAN P41595 B2R9D5 Q53TI1 Q62221 Q6P523 51258360 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cccc(O)c1 InChI=1S/C23H28N2O3/c1-18-22(27)25(20-8-5-9-21(26)16-20)17-23(28-18)11-14-24(15-12-23)13-10-19-6-3-2-4-7-19/h2-9,16,18,26H,10-15,17H2,1H3 SVTYKQJVCXBJNT-UHFFFAOYSA-N 50514254 CHEMBL4471711 Sigma non-opioid intracellular receptor 1 Homo sapiens 55 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514254&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567552 440722836 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258361 COc1cccc(c1)N1CC2(CCN(CCc3ccccc3)CC2)OC(C)C1=O InChI=1S/C24H30N2O3/c1-19-23(27)26(21-9-6-10-22(17-21)28-2)18-24(29-19)12-15-25(16-13-24)14-11-20-7-4-3-5-8-20/h3-10,17,19H,11-16,18H2,1-2H3 ZEIMIZKOLIBIEH-UHFFFAOYSA-N 50514227 CHEMBL4550656 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514227 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514227&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118562556 440722809 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258362 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cnccc1C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(20-15-27-11-7-19(20)23(24,25)26)16-22(31-17)9-13-28(14-10-22)12-8-18-5-3-2-4-6-18/h2-7,11,15,17H,8-10,12-14,16H2,1H3 LYDQCJJNPZBLSS-UHFFFAOYSA-N 50514270 CHEMBL4460762 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 3300 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514270 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514270&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118567538 440722852 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258363 CC1OC2(CCN(CCc3cccc(F)c3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H27FN2O2/c1-18-22(27)26(21-8-3-2-4-9-21)17-23(28-18)11-14-25(15-12-23)13-10-19-6-5-7-20(24)16-19/h2-9,16,18H,10-15,17H2,1H3 BDLPANZXJUPVDU-UHFFFAOYSA-N 50514259 CHEMBL4534193 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 600 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514259 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514259&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118562440 440722841 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258364 C[C@H]1OC2(CCN(CCc3ccccc3F)CC2)CN(C1=O)c1cnccc1C(F)(F)F |r| InChI=1S/C23H25F4N3O2/c1-16-21(31)30(20-14-28-10-6-18(20)23(25,26)27)15-22(32-16)8-12-29(13-9-22)11-7-17-4-2-3-5-19(17)24/h2-6,10,14,16H,7-9,11-13,15H2,1H3 INCPDVXLHDEOLM-UHFFFAOYSA-N 50514262 CHEMBL4576031 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 6300 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514262 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514262&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 126744972 440722844 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258365 Fc1ccccc1CCN1CCC2(CC1)CN(C(=O)C1(CC1)O2)c1cccnc1C(F)(F)F InChI=1S/C24H25F4N3O2/c25-18-5-2-1-4-17(18)7-13-30-14-10-22(11-15-30)16-31(21(32)23(33-22)8-9-23)19-6-3-12-29-20(19)24(26,27)28/h1-6,12H,7-11,13-16H2 QNSPFRSAEHVDGL-UHFFFAOYSA-N 50514245 CHEMBL4461774 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514245 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514245&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118567543 440722827 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258366 c1cc(ccc1C(=O)CCCN2CCC(CC2)(c3ccc(cc3)Cl)O)F InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2 LNEPOXFFQSENCJ-UHFFFAOYSA-N 21398 4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1-(4-fluoro-phenyl)-butan-1-one;propionate(HCl)::Haloperidol, 1::CHEMBL545608::CHEMBL54::4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one::Haloperidol::US20240317745, Compound haloperidol Mu-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21398 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=21398&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search GMJ 6DJZ,6LUQ,6X10 3559 49689470 CHEMBL54CHEMBL545608 DB00502 C01814 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258367 CC1OC2(CCN(CCc3cccc(NC(C)=O)c3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C25H31N3O3/c1-19-24(30)28(23-9-4-3-5-10-23)18-25(31-19)12-15-27(16-13-25)14-11-21-7-6-8-22(17-21)26-20(2)29/h3-10,17,19H,11-16,18H2,1-2H3,(H,26,29) GFMRIFXLIUPAFX-UHFFFAOYSA-N 50514242 CHEMBL4573960 Mu-type opioid receptor Homo sapiens 343 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514242 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514242&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 126744800 440722824 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258368 C[C@H]1OC2(CCN(CCc3ccccc3F)CC2)CN(C1=O)c1cnccc1C(F)(F)F |r| InChI=1S/C23H25F4N3O2/c1-16-21(31)30(20-14-28-10-6-18(20)23(25,26)27)15-22(32-16)8-12-29(13-9-22)11-7-17-4-2-3-5-19(17)24/h2-6,10,14,16H,7-9,11-13,15H2,1H3 INCPDVXLHDEOLM-UHFFFAOYSA-N 50514262 CHEMBL4576031 Mu-type opioid receptor Homo sapiens 26 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514262 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514262&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 126744972 440722844 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258369 CN1CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)OC InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3 BRUQQQPBMZOVGD-UHFFFAOYSA-N 50370595 US9233167, Oxycodone::Oxycontin::OXYCODONE::US1184575, oxycodone Sigma non-opioid intracellular receptor 1 Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50370595 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50370595&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search OOX 7U63 5284603 160849697 DB00497 C08026 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258370 C[C@H]1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 |r| InChI=1S/C23H28N2O2/c1-19-22(26)25(21-10-6-3-7-11-21)18-23(27-19)13-16-24(17-14-23)15-12-20-8-4-2-5-9-20/h2-11,19H,12-18H2,1H3 RSVBTLSIVBWMNF-UHFFFAOYSA-N 50514247 CHEMBL4450665 Sigma non-opioid intracellular receptor 1 Homo sapiens 21 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514247&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118562584 440722829 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258371 CN(C)C(=O)CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C26H33N3O3/c1-27(2)24(30)19-23-25(31)29(22-11-7-4-8-12-22)20-26(32-23)14-17-28(18-15-26)16-13-21-9-5-3-6-10-21/h3-12,23H,13-20H2,1-2H3 SGLYTKUAFQGFJG-UHFFFAOYSA-N 50514250 CHEMBL4458456 Sigma non-opioid intracellular receptor 1 Homo sapiens 275 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514250&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567549 440722832 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258372 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccc(nc1)C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(19-7-8-20(27-15-19)23(24,25)26)16-22(31-17)10-13-28(14-11-22)12-9-18-5-3-2-4-6-18/h2-8,15,17H,9-14,16H2,1H3 SBBYFXIXMFNMNQ-UHFFFAOYSA-N 50514258 CHEMBL4560624 Sigma non-opioid intracellular receptor 1 Homo sapiens 9.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514258&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567742 440722840 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258373 CC1OC2(CCN(CCc3cccc(NC(C)=O)c3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C25H31N3O3/c1-19-24(30)28(23-9-4-3-5-10-23)18-25(31-19)12-15-27(16-13-25)14-11-21-7-6-8-22(17-21)26-20(2)29/h3-10,17,19H,11-16,18H2,1-2H3,(H,26,29) GFMRIFXLIUPAFX-UHFFFAOYSA-N 50514242 CHEMBL4573960 Sigma non-opioid intracellular receptor 1 Homo sapiens 147 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514242 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514242&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 126744800 440722824 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258374 C[C@H]1OC2(CCN(CCc3cccc(NC(C)=O)c3)CC2)CN(C1=O)c1ccccc1 |r| InChI=1S/C25H31N3O3/c1-19-24(30)28(23-9-4-3-5-10-23)18-25(31-19)12-15-27(16-13-25)14-11-21-7-6-8-22(17-21)26-20(2)29/h3-10,17,19H,11-16,18H2,1-2H3,(H,26,29) GFMRIFXLIUPAFX-UHFFFAOYSA-N 50514231 CHEMBL4525653 Sigma non-opioid intracellular receptor 1 Homo sapiens 205 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514231 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514231&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 126744799 440722813 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258375 CCC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H30N2O2/c1-2-22-23(27)26(21-11-7-4-8-12-21)19-24(28-22)14-17-25(18-15-24)16-13-20-9-5-3-6-10-20/h3-12,22H,2,13-19H2,1H3 ZPNOUFCAZBAVMA-UHFFFAOYSA-N 50514248 CHEMBL4515812 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 400 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514248&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 118562510 440722830 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 51258376 O=C1COC2(CCN(CCc3ccccc3)CC2)CN1c1ccccc1 InChI=1S/C22H26N2O2/c25-21-17-26-22(18-24(21)20-9-5-2-6-10-20)12-15-23(16-13-22)14-11-19-7-3-1-4-8-19/h1-10H,11-18H2 DHIDSSXNRVGMDP-UHFFFAOYSA-N 50514276 CHEMBL4439908 Mu-type opioid receptor Homo sapiens 437 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514276 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514276&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567670 440722858 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258377 COc1ccccc1N1CC2(CCN(CCc3ccccc3)CC2)OC(C)C1=O InChI=1S/C24H30N2O3/c1-19-23(27)26(21-10-6-7-11-22(21)28-2)18-24(29-19)13-16-25(17-14-24)15-12-20-8-4-3-5-9-20/h3-11,19H,12-18H2,1-2H3 SKDFRXDSPIOUSP-UHFFFAOYSA-N 50514267 CHEMBL4526087 Mu-type opioid receptor Homo sapiens 57 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514267 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514267&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567744 440722849 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258378 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccncc1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-7-12-23-13-8-20)17-22(27-18)10-15-24(16-11-22)14-9-19-5-3-2-4-6-19/h2-8,12-13,18H,9-11,14-17H2,1H3 ZJJJQCGQCRZOBG-UHFFFAOYSA-N 50514269 CHEMBL4448710 Mu-type opioid receptor Homo sapiens >1000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514269&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562573 440722851 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258379 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1cccnc1C(F)(F)F InChI=1S/C23H26F3N3O2/c1-17-21(30)29(19-8-5-12-27-20(19)23(24,25)26)16-22(31-17)10-14-28(15-11-22)13-9-18-6-3-2-4-7-18/h2-8,12,17H,9-11,13-16H2,1H3 JHFOVHVTTIYFHX-UHFFFAOYSA-N 50514240 CHEMBL4535897 Mu-type opioid receptor Homo sapiens 123 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514240&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567545 440722822 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258380 O=C1C(COCc2ccccc2)OC2(CCN(CCc3ccccc3)CC2)CN1c1ccccc1 InChI=1S/C30H34N2O3/c33-29-28(23-34-22-26-12-6-2-7-13-26)35-30(24-32(29)27-14-8-3-9-15-27)17-20-31(21-18-30)19-16-25-10-4-1-5-11-25/h1-15,28H,16-24H2 OCSZOZIYXZJENV-UHFFFAOYSA-N 50514272 CHEMBL4528962 Mu-type opioid receptor Homo sapiens 40 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514272 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514272&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562576 440722854 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258381 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccc(O)cc1 InChI=1S/C23H28N2O3/c1-18-22(27)25(20-7-9-21(26)10-8-20)17-23(28-18)12-15-24(16-13-23)14-11-19-5-3-2-4-6-19/h2-10,18,26H,11-17H2,1H3 HEVHIURIMIMQGN-UHFFFAOYSA-N 50514277 CHEMBL4513933 Mu-type opioid receptor Homo sapiens 606 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514277 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514277&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118567550 440722859 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258382 CC1OC2(CCN(CCc3ccccc3F)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H27FN2O2/c1-18-22(27)26(20-8-3-2-4-9-20)17-23(28-18)12-15-25(16-13-23)14-11-19-7-5-6-10-21(19)24/h2-10,18H,11-17H2,1H3 ZAIUBAOMYCTCCK-UHFFFAOYSA-N 50514232 CHEMBL4536259 Mu-type opioid receptor Homo sapiens 6.0 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514232&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562384 440722814 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258383 CCC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C24H30N2O2/c1-2-22-23(27)26(21-11-7-4-8-12-21)19-24(28-22)14-17-25(18-15-24)16-13-20-9-5-3-6-10-20/h3-12,22H,2,13-19H2,1H3 ZPNOUFCAZBAVMA-UHFFFAOYSA-N 50514248 CHEMBL4515812 Mu-type opioid receptor Homo sapiens 1.000000 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514248&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562510 440722830 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258384 O=C1COC2(CCN(Cc3ccccc3)CC2)CN1c1ccccc1 InChI=1S/C21H24N2O2/c24-20-16-25-21(17-23(20)19-9-5-2-6-10-19)11-13-22(14-12-21)15-18-7-3-1-4-8-18/h1-10H,11-17H2 KBEJBFGBZGNZHJ-UHFFFAOYSA-N 50514263 CHEMBL4446292 Sigma non-opioid intracellular receptor 1 Homo sapiens 26 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514263 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514263&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567654 440722845 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0 51258385 OCC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C23H28N2O3/c26-17-21-22(27)25(20-9-5-2-6-10-20)18-23(28-21)12-15-24(16-13-23)14-11-19-7-3-1-4-8-19/h1-10,21,26H,11-18H2 QGQRUYNHBMRUGE-UHFFFAOYSA-N 50514266 CHEMBL4459117 Mu-type opioid receptor Homo sapiens 46 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514266 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514266&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562362 440722848 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258386 CC1OC2(CCN(CCc3ccccn3)CC2)CN(C1=O)c1ccccc1 InChI=1S/C22H27N3O2/c1-18-21(26)25(20-8-3-2-4-9-20)17-22(27-18)11-15-24(16-12-22)14-10-19-7-5-6-13-23-19/h2-9,13,18H,10-12,14-17H2,1H3 QPMLJPMWNURBDC-UHFFFAOYSA-N 50514274 CHEMBL4473746 Mu-type opioid receptor Homo sapiens 90 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514274 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514274&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 118562598 440722856 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51258387 CC1OC2(CCN(CCc3ccccc3)CC2)CN(C1=O)c1ccc(O)cc1 InChI=1S/C23H28N2O3/c1-18-22(27)25(20-7-9-21(26)10-8-20)17-23(28-18)12-15-24(16-13-23)14-11-19-5-3-2-4-6-19/h2-10,18,26H,11-17H2,1H3 HEVHIURIMIMQGN-UHFFFAOYSA-N 50514277 CHEMBL4513933 Sigma non-opioid intracellular receptor 1 Homo sapiens 122 ChEMBL 10.1021/acs.jmedchem.9b01256 10.7270/Q2PZ5D5K 31743642 García, M; Virgili, M; Alonso, M; Alegret, C; Fernández, B; Port, A; Pascual, R; Monroy, X; Vidal-Torres, A; Serafini, MT; Vela, JM; Almansa, C 3/12/2020 2/21/2021 Esteve Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514277 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000996&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514277&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 118567550 440722859 1 MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP 6DK1,6DK0,6DJZ,5HK2,5HK1 Sigma non-opioid intracellular receptor 1 SGMR1_HUMAN Q99720 D3DRM7 O00673 O00725 Q0Z9W6 Q153Z1 Q2TSD1 Q53GN2 Q7Z653 Q8N7H3 Q9NYX0